RE:RE:RE:RE:RE:Gritstone oncology The Gritstone development is sort of the classes research Biotech kind of deal. They come up with the science, sell it off, and keep a residual. They're essentially given a massive chunk of future revenues for the investment now. Can make a lot of sense, but don't think THTX was thinking in those terms. Nonetheless, can't argue with the shareholder rewards they've created with it. That credibility is something I hope THTX brings in post any good oncology news. But others here have said it you get that kind of news, you're better off keeping 100% of the revenues which is probably right. Either way, you win.
On the deal, I don't think they are the type to have been playing around in a cheeky manner with possible future bad or good news they knew of. Just not their style it seems and way to conservative. I can square the whole deal up with just the fact they signed up for expensive trials by getting two approvals from the FDA. The Boad wanted to see the money in the bank as soon as possible. Just super conservative and the combination of that and lack of real banking expertise resulted in a rushed, bad deal. But it was the simplest way to do what they wanted, when they wanted.